KRAS and lung carcinoma: Delayed tumor onset and reduced tumor growth rate observed in the AJEJJenv infected Akt1−/− mice was consistent with the findings of Hollander et al[19], which showed that loss of Akt1 prevented tumor initiation and tumor progression in both a carcinogen-induced and a mutant K-ras-induced mouse model of lung cancer.